These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 7861706

  • 1. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members.
    Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P.
    Kidney Int; 1994 Oct; 46(4):1118-23. PubMed ID: 7861706
    [Abstract] [Full Text] [Related]

  • 2. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE, Wilson DM, Burnett JC, Johnson CM, Offord KP.
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [Abstract] [Full Text] [Related]

  • 3. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN, Florijn KW, Muizert Y, Chang PC.
    Nephrol Dial Transplant; 1995 Oct; 10(8):1332-41. PubMed ID: 8538923
    [Abstract] [Full Text] [Related]

  • 4. Effect of enalapril on blood pressure, renal function, and the renin-angiotensin-aldosterone system in cats with autosomal dominant polycystic kidney disease.
    Miller RH, Lehmkuhl LB, Smeak DD, DiBartola SP, Radin J.
    Am J Vet Res; 1999 Dec; 60(12):1516-25. PubMed ID: 10622161
    [Abstract] [Full Text] [Related]

  • 5. Renal vascular resistance and renin-angiotensin system in the pathogenesis of early hypertension in autosomal dominant polycystic kidney disease.
    Ramunni A, Saracino A, Esposito T, Saliani MT, Coratelli P.
    Hypertens Res; 2004 Apr; 27(4):221-5. PubMed ID: 15127878
    [Abstract] [Full Text] [Related]

  • 6. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease.
    Chapman AB, Johnson A, Gabow PA, Schrier RW.
    N Engl J Med; 1990 Oct 18; 323(16):1091-6. PubMed ID: 2215576
    [Abstract] [Full Text] [Related]

  • 7. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM, Al-Nimri MA, Oyama TT, Thompson MM, Kelly FJ, Chapman JG, Anderson S.
    Kidney Int; 1999 Dec 18; 56(6):2181-90. PubMed ID: 10594794
    [Abstract] [Full Text] [Related]

  • 8. The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients.
    Doulton TW, Saggar-Malik AK, He FJ, Carney C, Markandu ND, Sagnella GA, MacGregor GA.
    J Hypertens; 2006 May 18; 24(5):939-45. PubMed ID: 16612257
    [Abstract] [Full Text] [Related]

  • 9. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RW.
    Am J Kidney Dis; 2000 Mar 18; 35(3):427-32. PubMed ID: 10692268
    [Abstract] [Full Text] [Related]

  • 10. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
    Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW.
    Nephrol Dial Transplant; 1999 May 18; 14(5):1113-6. PubMed ID: 10344347
    [Abstract] [Full Text] [Related]

  • 11. Renal effects of atrial natriuretic factor during control of the renin-angiotensin system in anesthetized dogs.
    Seymour AA, Mazack EK.
    Circ Res; 1988 Mar 18; 62(3):506-14. PubMed ID: 2830044
    [Abstract] [Full Text] [Related]

  • 12. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
    Grandis DJ, Uretsky BF, Verbalis JG, Chong TK, Puschett JB.
    Am J Hypertens; 1992 Nov 18; 5(11):793-9. PubMed ID: 1457079
    [Abstract] [Full Text] [Related]

  • 13. Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease.
    Harrap SB, Davies DL, Macnicol AM, Dominiczak AF, Fraser R, Wright AF, Watson ML, Briggs JD.
    Kidney Int; 1991 Sep 18; 40(3):501-8. PubMed ID: 1838571
    [Abstract] [Full Text] [Related]

  • 14. The pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
    Wang D, Strandgaard S.
    J Hypertens; 1997 Sep 18; 15(9):925-33. PubMed ID: 9321739
    [Abstract] [Full Text] [Related]

  • 15. Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
    Graffe CC, Bech JN, Lauridsen TG, Pedersen EB.
    Am J Physiol Renal Physiol; 2012 Apr 15; 302(8):F917-27. PubMed ID: 22262484
    [Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease.
    Watson ML, Macnicol AM, Allan PL, Wright AF.
    Kidney Int; 1992 Jan 15; 41(1):206-10. PubMed ID: 1317477
    [Abstract] [Full Text] [Related]

  • 17. Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.
    Schlaich MP, Klingbeil AU, Jacobi J, Delles C, Schneider MP, Schmidt BM, Schmieder RE.
    J Hypertens; 2002 Jan 15; 20(1):117-24. PubMed ID: 11791034
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents.
    van Hooft IM, Grobbee DE, Derkx FH, de Leeuw PW, Schalekamp MA, Hofman A.
    N Engl J Med; 1991 May 09; 324(19):1305-11. PubMed ID: 2017226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.